I tend to agree too... However it's hard to see what partnerships would bring to the table at this late stage. The trials are running to completion (and assuming the outcomes are positive), the manufacturing and logistics seem to be in place (assuming they can scale as required).
The products will sell themselves there is absolutely no need to market them, at least in the initial stages. So that leaves a website, some accounts receivable personnel to be hired...
Silvui on Bloomberg, page-8
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2482 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 27045 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |